NCAM1 and B-cell chronic lymphocytic leukemia: The scFvB1IL15 immunocytokine, described in this manuscript, directs IL15 to NK cells through specific binding to the CD56 antigen and restores the NK population in CLL patients to its physiological functions in a targeted way.